(Q36273188)

English

Pharmacodiagnostic testing in breast cancer: focus on HER2 and trastuzumab therapy

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

title

Pharmacodiagnostic testing in breast cancer: focus on HER2 and trastuzumab therapy (English)

1 reference

stated in

Europe PubMed Central

13 August 2017

1 reference

John M S Bartlett

1

1 reference

stated in

Europe PubMed Central

13 August 2017

1 January 2005

1 reference

stated in

Europe PubMed Central

13 August 2017

Molecular Diagnosis and Therapy

1 reference

stated in

Europe PubMed Central

13 August 2017

5

1 reference

stated in

Europe PubMed Central

13 August 2017

303-315

1 reference

stated in

Europe PubMed Central

13 August 2017

5

1 reference

stated in

Europe PubMed Central

13 August 2017

https://scigraph.springernature.com/pub.10.2165/00129785-200505050-00003

0 references

cites work

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2165%2F00129785-200505050-00003

retrieved

21 January 2018

Identifiers

DOI

10.2165/00129785-200505050-00003

1 reference

stated in

Europe PubMed Central

PubMed ID

16196500

retrieved

13 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

PubMed ID

16196500

retrieved

13 August 2017

(Q36273188)

Pharmacodiagnostic testing in breast cancer: focus on HER2 and trastuzumab therapy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)